title: Repeated histamine pretreatment decreased amnesia induced by post-training administration of the drug in a step-down inhibitory avoidance test in mice.
abstract: BACKGROUND
  Repeated administration of certain drugs could result in an enhancement of the behavioral effects of those drugs. In the present study, the effect of repeated administration of histamine on amnesia induced by post-training administration of the drug was examined.
  
  
  METHODS
  A single trial step-down inhibitory (passive) avoidance task was used for memory assessment in male NMRI mice.
  
  
  RESULTS
  The results showed that post-training administration of different doses of histamine (5, 10, and 20 microg/mouse, i.c.v.) decreased the step-down latency on the test day. Repeated pretreatment of histamine (10 and 20 microg/mouse) for three days followed by five days of no drug treatment prevented amnesia due to post-training histamine (20 microg/mouse). In contrast, repeated administration of histamine H1 receptor antagonist, pyrilamine (5, 10, and 20 mg/kg) or histamine H2 receptor antagonist, ranitidine (12.5 and 25 mg/kg) 10 minutes prior to histamine injections, decreased the effect of repeated histamine administration. Moreover, a similar pattern was seen in animals which received dopamine D1 receptor antagonist, SCH 23390 (0.025, 0.5, and 1 mg/kg) or dopamine D2 receptor antagonist, sulpiride (0.2, 1, and 5 mg/kg) 10 minutes prior to histamine injections during the repeated pretreatment.
  
  
  CONCLUSIONS
  The results indicated that both the histamine and dopamine receptor mechanisms may be involved in the effects of repeated pretreatment of histamine on drug induced amnesia.
authors.affiliation: Department of Biological Science and Biotechnology, Faculty of Science, University of Kurdistan, Sanandaj, Iran.
authors.forename: Shamseddin
authors.initials: S
authors.lastname: Ahmadi
authors.forename: Nazanin
authors.initials: N
authors.lastname: Malekmohammadi
authors.forename: Mohammad Reza
authors.initials: MR
authors.lastname: Zarrindast
mesh_terms: D000647:Amnesia / Q000139:chemically induced / Q000517:prevention & control*; D000704:Analysis of Variance; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D001522:Behavior, Animal / Q000187:drug effects*; D001552:Benzazepines / Q000494:pharmacology; D004195:Disease Models, Animal; D018492:Dopamine Antagonists / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D006632:Histamine / Q000008:administration & dosage*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D011336:Probability; D011738:Pyrilamine / Q000494:pharmacology; D011897:Random Allocation; D018709:Statistics, Nonparametric; D013469:Sulpiride / Q000494:pharmacology
chemical_list: D001552:Benzazepines; D018492:Dopamine Antagonists; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; C534628:SCH 23390; D013469:Sulpiride; D006632:Histamine; D011738:Pyrilamine